Facility
Current Manufacturing Facility: IDA Cherlapally, Hyderabad, India
The manufacturing unit is situated at IDA Cherlapally, Hyderabad, India – renowned as one of the premier industrial zones in India, covering an extent of 2,500 sq. yards, with a built up area of 25,000 sq. ft. With an unwavering commitment to safety, health, and environmental protection, we ensure a secure and responsible production environment.
Our state-of-the-art ISO 9001:2015 and GMP certified facility has fully equipped machinery and equipment for producing high quality immediate and controlled release pellets. The facility is supported with the requisite utility systems along with instruments and support services like HVAC system required for the processes within the unit.
We implement cGMP across our manufacturing facility, which is monitored by a quality management system encompassing key areas of business processes from R&D and raw material procurement to manufacturing, packaging and delivery. We have consistently surpassed expectations by not only clearing numerous customer audits but also exceeding performance standards. Our commitment to continuous development, along with frequent upgradations and strict adherence to GMP and environmental standards ensures exceptional quality in customer service. Over time, as our company has advanced its operations, we have become an ideal ally for businesses and operations in the domestic market and also exporting our products to different countries and serving not only our needs, but those of other companies.
Upcoming Facility: Karakapatla Biotech Park, Hyderabad
Exciting developments are on the horizon with our upcoming expansion project at Karakapatla Biotech Park, Hyderabad. This visionary project, set on 1.8 acres, is slated to become a cutting-edge facility spanning 50,000 square feet. Located a mere 35 kilometers from our existing site, this expansion signifies our strategic evolution into finished dosage forms from semi-finished formulations. As construction progresses, we eagerly anticipate unveiling a facility that not only meets but exceeds industry standards, propelling us into a new era of excellence. Stay tuned for updates on our progress and the unfolding chapters of our growth story.
Research and Development
At Rashmi Pharma, we take pride in our dynamic and forward-thinking Research and Development (R&D) department, dedicated to crafting customized pellet formulations tailored to meet our customers' unique requirements. Our commitment to excellence is evident in our proactive approach to developing new products in response to market demands.
Customized Pellet Formulations:
Our R&D team thrives on the challenge of customization. We understand that every customer has distinct needs, and we take pride in our ability to formulate pellets that precisely align with those requirements. This bespoke approach sets us apart, ensuring that our clients receive formulations that not only meet but exceed their expectations.
Innovative Solutions for Market Demands:
Staying at the forefront of industry trends, we actively respond to market demands by introducing cutting-edge products. Our commitment to innovation is exemplified in our embrace of technologies such as MUPS (Multiple Unit Pellet System) and SUBA (Super Bioavailability) technology. These advancements not only showcase our dedication to staying ahead but also underline our commitment to delivering high-quality, effective pharmaceutical solutions.
Guided by Expertise:
A cornerstone of our success lies in the vast experience held by our founding Managing Director. With a wealth of knowledge in the pharmaceutical industry, their leadership ensures that Rashmi Pharma continually stands out as a beacon of excellence. This invaluable expertise is woven into the fabric of our R&D processes, guiding our team towards innovative breakthroughs and maintaining our consistent position in the industry.